Ruth Handler's creation of Barbie was inspired by her daughter's preference for adult-shaped dolls, leading to a ...

Kimberly Alexander's caregiving experience revealed a lack of awareness and support for multiple myeloma, especially in the ...

October brought several updates in the lung cancer field, ranging from notable trial results to patient-centered perspectives ...

CureWise, the AI-powered platform Steve originally developed to help with his own rare blood cancer diagnosis, has evolved ...

The FDA approved Darzalex Faspro for the treatment of adults with high-risk smoldering multiple myeloma. The U.S. Food and ...

Jeannine Walston has a survivorship story of more than 25 years to share. Walston, who has contributed to CURE as a blogger ...

Throughout October, CURE highlighted research developments and evolving treatment strategies that continue to shape cancer ...

Venkataraman, director of Sarcoma Pathways and physician at Dana-Farber Cancer Institute, in Boston, explained that treatment ...

Steve Brown and Lisa Booth sat down for a joint interview with CURE to discuss the future of patient-driven artificial intelligence in cancer care.

Steve Brown and Lisa Booth sat down for a joint interview with CURE to discuss the future of patient-driven artificial intelligence in cancer care.

Amtagvi monotherapy achieved a 25.6% objective response rate and 71.8% disease control rate in NSCLC patients without ...

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to M2T-CD33 (LTI-214) for the treatment of ...